Prasheen Agarwal

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

Jörge E. Cortes, Philippe Rousselot, Dong‐Wook Kim et al. · Blood · 2006 · 418 citations

Medicine, Hematology, Oncology +16

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

François Guilhot, Jane F. Apperley, Dong‐Wook Kim et al. · Blood · 2007 · 372 citations · Full text

Medicine, Hematology, Oncology +14

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial

Philip J. Mease, Proton Rahman, Alice B. Gottlieb et al. · The Lancet · 2020 · 344 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

Atul Deodhar, Philip Helliwell, Wolf‐­Henning Boehncke et al. · The Lancet · 2020 · 322 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis

Marc A. Judson, Robert P. Baughman, Ulrich Costabel et al. · European Respiratory Journal · 2014 · 212 citations

Life Sciences, Immunology, Pharmacotherapy +16